Phase 3 Trial of NCX 470 vs. Latanoprost in Subjects With Open-Angle Glaucoma or Ocular Hypertension
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Ocular Hypertension
- Open Angle Glaucoma
- Type
- Interventional
- Phase
- Phase 3
- Design
- Allocation: RandomizedIntervention Model: Parallel AssignmentMasking: Double (Participant, Investigator)Masking Description: double-maskedPrimary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 84 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT04445519
- Collaborators
- Not Provided
- Investigators
- Study Director: Jose L Boyer, PhD Nicox Ophthalmics, Inc.